Metabolic/hypoxial axis predicts tamoxifen resistance in breast cancer

We sought in our cross-sectional study to investigate the role of metabolic/hypoxial axis in the development of tamoxifen (TMX) resistance in BC patients. Quantification of plasma LncRNA Taurine upregulated-1 (TUG-1), miRNA 186-5p (miR-186), serum Sirtuin-3 (SIRT3), Peroxisome Proliferator Activator...

Descripción completa

Detalles Bibliográficos
Autores principales: Azzam, Hany N., El-Derany, Marwa O., Wahdan, Sara A., Faheim, Reham M., Helal, Gouda K., El-Demerdash, Ebtehal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515205/
https://www.ncbi.nlm.nih.gov/pubmed/36167713
http://dx.doi.org/10.1038/s41598-022-19977-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515205/
https://www.ncbi.nlm.nih.gov/pubmed/36167713
http://dx.doi.org/10.1038/s41598-022-19977-w

Ejemplares similares